Barbara Szymanska

733 total citations
7 papers, 499 citations indexed

About

Barbara Szymanska is a scholar working on Public Health, Environmental and Occupational Health, Molecular Biology and Neurology. According to data from OpenAlex, Barbara Szymanska has authored 7 papers receiving a total of 499 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Public Health, Environmental and Occupational Health, 3 papers in Molecular Biology and 2 papers in Neurology. Recurrent topics in Barbara Szymanska's work include Acute Lymphoblastic Leukemia research (6 papers), Neuroblastoma Research and Treatments (2 papers) and Cell death mechanisms and regulation (2 papers). Barbara Szymanska is often cited by papers focused on Acute Lymphoblastic Leukemia research (6 papers), Neuroblastoma Research and Treatments (2 papers) and Cell death mechanisms and regulation (2 papers). Barbara Szymanska collaborates with scholars based in Australia, United States and Italy. Barbara Szymanska's co-authors include Richard B. Lock, Min H. Kang, C. Patrick Reynolds, Hernán Carol, Ingrid Boehm, Yun Hee Kang, Michael A. Sheard, Seong Lin Khaw, Nicole Barber and Ingela B. Vikstrom and has published in prestigious journals such as Blood, PLoS ONE and Clinical Cancer Research.

In The Last Decade

Barbara Szymanska

7 papers receiving 496 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Barbara Szymanska Australia 6 306 155 140 125 77 7 499
Rachael A. Papa Australia 9 228 0.7× 192 1.2× 125 0.9× 117 0.9× 47 0.6× 12 431
Agnieszka A. Wendorff United States 6 446 1.5× 139 0.9× 99 0.7× 179 1.4× 114 1.5× 8 642
Eulàlia Genescà Spain 11 242 0.8× 216 1.4× 193 1.4× 151 1.2× 44 0.6× 24 518
Yebin Ahn United States 3 389 1.3× 238 1.5× 102 0.7× 251 2.0× 59 0.8× 4 601
Katherine M. LaFiura United States 8 331 1.1× 128 0.8× 166 1.2× 191 1.5× 95 1.2× 8 555
Kaat Durinck Belgium 13 335 1.1× 111 0.7× 93 0.7× 98 0.8× 178 2.3× 26 548
Luca Trentin Italy 15 381 1.2× 154 1.0× 81 0.6× 178 1.4× 126 1.6× 25 556
Sonya H.L. Lam Canada 10 292 1.0× 80 0.5× 185 1.3× 78 0.6× 93 1.2× 15 466
Ingrid M. Ariës Netherlands 7 317 1.0× 95 0.6× 99 0.7× 85 0.7× 112 1.5× 9 494
Christian Hurtz United States 10 246 0.8× 162 1.0× 115 0.8× 258 2.1× 43 0.6× 32 607

Countries citing papers authored by Barbara Szymanska

Since Specialization
Citations

This map shows the geographic impact of Barbara Szymanska's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbara Szymanska with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbara Szymanska more than expected).

Fields of papers citing papers by Barbara Szymanska

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barbara Szymanska. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbara Szymanska. The network helps show where Barbara Szymanska may publish in the future.

Co-authorship network of co-authors of Barbara Szymanska

This figure shows the co-authorship network connecting the top 25 collaborators of Barbara Szymanska. A scholar is included among the top collaborators of Barbara Szymanska based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barbara Szymanska. Barbara Szymanska is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Carol, Hernán, Barbara Szymanska, Kathryn Evans, et al.. (2013). The Anti-CD19 Antibody–Drug Conjugate SAR3419 Prevents Hematolymphoid Relapse Postinduction Therapy in Preclinical Models of Pediatric Acute Lymphoblastic Leukemia. Clinical Cancer Research. 19(7). 1795–1805. 57 indexed citations
2.
Szymanska, Barbara, Min H. Kang, Natalia Liem, et al.. (2012). Pharmacokinetic Modeling of an Induction Regimen for In Vivo Combined Testing of Novel Drugs against Pediatric Acute Lymphoblastic Leukemia Xenografts. PLoS ONE. 7(3). e33894–e33894. 43 indexed citations
3.
Szymanska, Barbara, Hernán Carol, Ingrid Boehm, et al.. (2012). Molecular determinants of T-cell acute lymphoblastic leukaemia sensitivity to the pre-prodrug PR-104. 3. 1 indexed citations
4.
Benito, Juliana, Yuexi Shi, Barbara Szymanska, et al.. (2011). Pronounced Hypoxia in Models of Murine and Human Leukemia: High Efficacy of Hypoxia-Activated Prodrug PR-104. PLoS ONE. 6(8). e23108–e23108. 98 indexed citations
5.
Bachmann, Petra, Rocco Piazza, Mary E. Janes, et al.. (2010). Epigenetic silencing of BIM in glucocorticoid poor-responsive pediatric acute lymphoblastic leukemia, and its reversal by histone deacetylase inhibition. Blood. 116(16). 3013–3022. 94 indexed citations
6.
Szymanska, Barbara, Nicole Barber, Seong Lin Khaw, et al.. (2009). The Bcl-2 Homology Domain 3 Mimetic ABT-737 Targets the Apoptotic Machinery in Acute Lymphoblastic Leukemia Resulting in Synergistic in Vitro and in Vivo Interactions with Established Drugs. Molecular Pharmacology. 77(3). 483–494. 93 indexed citations
7.
Kang, Min H., Yun Hee Kang, Barbara Szymanska, et al.. (2007). Activity of vincristine, L-ASP, and dexamethasone against acute lymphoblastic leukemia is enhanced by the BH3-mimetic ABT-737 in vitro and in vivo. Blood. 110(6). 2057–2066. 113 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rachael A. Papa Breakdown of academic impact, for papers by Agnieszka A. Wendorff Breakdown of academic impact, for papers by Eulàlia Genescà Breakdown of academic impact, for papers by Yebin Ahn Breakdown of academic impact, for papers by Katherine M. LaFiura Breakdown of academic impact, for papers by Kaat Durinck Breakdown of academic impact, for papers by Luca Trentin Breakdown of academic impact, for papers by Sonya H.L. Lam Breakdown of academic impact, for papers by Ingrid M. Ariës Breakdown of academic impact, for papers by Christian Hurtz
Rankless by CCL
2026